|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 43/04 | |
| C07H 15/04 |
| (11) | Number of the document | 2900061 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13837458.2 |
| Date of filing the European patent application | 2013-09-17 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/060182 |
| Date | 2013-09-17 |
| (87) | Number | WO 2014/043708 |
| Date | 2014-03-20 |
| (30) | Number | Date | Country code |
| 201261701914 P | 2012-09-17 | US | |
| 201361756818 P | 2013-01-25 | US | |
| 201361759532 P | 2013-02-01 | US |
| (72) |
TRABER, Peter, G., US
REDMOND, William,L., US
ZOMER, Eliezer, US
KLYOSOV, Anatole, US
LINCH, Stefanie, N., US
|
| (73) |
Galectin Therapeutics Inc.,
4960 Peachtree Industrial Blvd. Suite 240, Norcross, GA 30071,
US
Providence Health & Services Oregon d/b/a Earle A. Chiles Research Institute of the Robert W. Franz Cancer Res. Cent., 4805 NE Gilsan Street, 2N35, Portland, OR 97213, US |
| (54) | METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT |
| METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT |